Ordering Recommendation

Recommended test to confirm a hereditary cause of thyroid cancer in individuals with a personal or family history of thyroid cancer.

To compare this test to other hereditary cancer panels, refer to the ARUP Hereditary Cancer Panel Comparison table.

New York DOH Approval Status

This test is not New York state approved. There are no New York state-approved laboratories available. Submit a Non-Permitted Laboratory Request Form (NPL) to the NYDOH prior to collection of specimen. If NPL is approved by NYDOH, and sample is received at ARUP, testing will be performed.

Specimen Required

Patient Preparation
Collect

Lavender or pink (EDTA) or yellow (ACD Solution A or B).
New York State Clients: Lavender (EDTA)

Specimen Preparation

Transport 3 mL whole blood. (Min: 2 mL)
New York State Clients: 5 mL (Min: 2 mL)

Storage/Transport Temperature

Refrigerated

Unacceptable Conditions

Serum or plasma; grossly hemolyzed or frozen specimen; saliva; buccal brush, or swab; FFPE tissue.

Remarks
Stability

Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
New York State Clients: Ambient: 24 hours; Refrigerated: 1 week; Frozen: Unacceptable

Methodology

Massively Parallel Sequencing/Sequencing

Performed

Varies

Reported

10-15 days

Reference Interval

By report

Interpretive Data

Refer to report.

Compliance Category

Laboratory Developed Test (LDT)

Note

GENES TESTED: APC*; DICER1; MEN1*; PRKAR1A; PTEN*; RET; TP53
*One or more exons are not covered by sequencing and/or deletion/duplication analysis for the indicated gene; see Additional Technical Information.

Hotline History

N/A

CPT Codes

81201; 81203; 81404; 81405; 81321; 81323; 81406; 81351; 81479

Components

Component Test Code* Component Chart Name LOINC
3005945 THYCAN Specimen 66746-9
3005947 THYCAN Interp 50398-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • AFAP
  • Cowden syndrome
  • Familial adenomatous polyposis
  • Familial medullary thyroid carcinoma (FMTC)
  • Familial thyroid cancer
  • FAP
  • Li-Fraumeni syndrome
  • Medullary carcinoma of the thyroid
  • Multiple endocrine neoplasia
Hereditary Thyroid Cancer Panel, Sequencing and Deletion/Duplication